Should checkpoint inhibitors be reserved for biomarker-selected pediatric brain tumors?

• by Yaxel Levin-Carrion, Jayant Bhasin, Kevin Titkov, Sraavya Anne, Arman Sawhney, Caryn J. Ha, Ibraheem Sharaf, Marvens Jean, Jacob Santana, Drew Thibault, Alejandro Pando, Nemanja Novakovic, Nehal S. Parikh, Morana Vojnic, Jonathan H. Sherman

• May 16, 2026

First Patient Treated with Proton Therapy at Lynn Cancer Institute

The Eugene M. & Christine E. Lynn Cancer Institute at Boca Raton Regional Hospital, part of Baptist Health, reached an important milestone in the advancement of cancer care with the successful treatment of its first patient utilizing proton therapy, according to physicians at both the Institute and the hospital.

• by

• May 15, 2026

• 5 min

Sigmoidoscopy Reduces CRC Incidence Rates in Men in Norwegian Screening Study

Offering sigmoidoscopy screening led to reduced incidence of colorectal cancer, though more for men vs women, and a reduced rate of colorectal cancer–related mortality in men, according to findings fr...

• by The ASCO Post Staff

• May 15, 2026

• 3 min

Local Salvage Therapy for Post-Radiotherapy Local Recurrence of Prostate Cancer

In a systematic review and meta-analysis reported in JAMA Oncology, Miszczyk et al found that local therapies alone are associated with “reasonable efficacy” in select patients with locally radiorecur...

• May 15, 2026

• 2 min